Chemotherapy in advanced nonsmall cell lung cancer: indication, intensity, and duration.
AffiliationCRC Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, United Kingdom.
MetadataShow full item record
AbstractPlatinum-based combination and single-agent chemotherapy have become accepted as treatments for locally advanced and metastatic nonsmall cell lung cancer as a consequence of improved survival, quality of life, and symptom control compared with best supportive care. However, it is clear that a therapeutic plateau has been reached with current combinations requiring a re-evaluation of strategies to improve clinical outcomes. Dose intensification may offer one way in which to achieve better results, as may extension of the duration of treatment. The evidence suggests that dose intensification is a useful tool, and that its use in combination with markers of treatment duration and cumulative dose may help to maximize results from current active drug combinations.
CitationChemotherapy in advanced nonsmall cell lung cancer: indication, intensity, and duration. 2002, 14 (2):191-8 Curr Opin Oncol
JournalCurrent Opinion in Oncology
- Chemotherapy for advanced non-small cell lung cancer in the elderly population.
- Authors: Santos FN, Castria TB, Cruz MR, Riera R
- Issue date: 2016 Sep-Oct
- First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
- Authors: Greenhalgh J, Dwan K, Boland A, Bates V, Vecchio F, Dundar Y, Jain P, Green JA
- Issue date: 2016 May 25
- Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival.
- Authors: Lilenbaum RC, Langenberg P, Dickersin K
- Issue date: 1998 Jan 1
- Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.
- Authors: Yang ZY, Liu L, Mao C, Wu XY, Huang YF, Hu XF, Tang JL
- Issue date: 2014 Nov 17
- Cytotoxic chemotherapy in advanced non-small cell lung cancer: a review of standard treatment paradigms.
- Authors: Socinski MA
- Issue date: 2004 Jun 15